LONDON (Reuters) – Japan’s Takeda Pharmaceutical has sweetened its 44 billion-pound ($61.4 billion) bid for Shire as it races to agree terms with the British drugmaker before a deadline to strike a deal expires on Wednesday.
Source:: Reuters – Business News
